Skip to Content

CNET Reports from EmTech08

Martin LaMoinca analyzes Vinod Khosla’s keynote on renewable energy and a panel on “Green Transportation”.
September 24, 2008

Senior writer Martin LaMonica of CNET writes about Vinod Khosla, Founder of Khosla Ventures, keynote speech at Technology Review’s Emerging Technologies Conference:

Khosla: Crazy clean-tech ideas yield breakthroughs
Famed investor Vinod Khosla is one of the clean-tech industry’s most vocal cheerleaders. But most of today’s clean technologies fall short of his 1-billion-car test.

“If it doesn’t scale, it doesn’t matter,” says Khosla. “Most of what we talk about today–hybrid, biodiesel, ethanol, solar photovoltaics, geothermal–I believe are irrelevant to the scale of the problem” of climate change…read more

LaMonica also analyzes a panel discussion on green transportation and one of its panelist, JB Straubel, the chief technology officer of Tesla Motors:

What road to greener transportation?
The route to a less polluting car looks more like a multipoint intersection than a single superhighway, a panel of experts said on Wednesday.

The auto and fuels industries are in the midst of dramatic technological change, but it’s still not clear how quickly which new technologies will be adopted…read more

Tesla’s ‘Bluestar’ to be all-electric family car
Tesla Motors has received many accolades for producing an all-electric luxury sports car. But its long-term plans may hold its most challenging task: making a mass-market electric car…read more

Keep Reading

Most Popular

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

images created by Google Imagen
images created by Google Imagen

The dark secret behind those cute AI-generated animal images

Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.